Healthcare News - An Overview
Novo CEO pressed by Senate to chop selling prices of being overweight, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the business would think about new talks with insurers with regards to the record costs of Wegovy and copyright should they pledge to maintain the medicines on their formularies.Insurers will